Oral Drug Delivery Resources
-
Factors To Consider When Selecting A CDMO For Complex Injectables Development And Manufacture
3/1/2022
The right CDMO partner will have specialized technologies for complex injectable development along with the equipment, facilities and operations to adopt GMP practices with a "laboratory setting."
-
Making The Right Choice For Multiparticulate Modified Release Dosage Forms
4/2/2021
Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.
-
Zydis® Orally Disintegrating Tablet (ODT) Vs. Standard Tablets (ST)
7/28/2023
Review how Zydis ODT compares against standard oral tablets, how the same molecule can produce a different outcome when utilizing Zydis ODT, and findings from over 20 published studies.
-
10 Ways To Align Your Medical Device With Human Factors Industry Best Practices
3/1/2024
Discover how patient-centric design principles can improve the development of medical devices. By focusing on user needs and behaviors, manufacturers can ensure that products align with expectations.
-
Customized Release Through Dispersed Dosage Formats
6/13/2024
Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.
-
High Potent Formulation Development In Oncology
6/1/2023
Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.
-
Layer By Layer: 3D Screen Printing And The Future Of Drug Development
8/15/2025
3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.
-
Partnering For Success In Sustained Drug Delivery Formulations
3/18/2022
With a focus on the sustained and controlled drug delivery segment of the pharmaceutical market, learn about technology platforms, support services, and sustainable solutions.
-
Nanosuspension Dosage Forms: Product Development & Scale Up
2/8/2022
For drug nanosuspensions, parameters like stabilizer concentration, drug loading, milling speed, milling time, bead diameter/density, and temperature are important formulation and process variables.
-
Reshaping Drug Development With 3D Screen Printing
8/15/2025
Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.